Calmsie

The current children's mental health care system misses 80% of kids in need. Calmsie’s solution, Mission Amygdala, is a multi-modal personalized experience adjusted to childrens’ needs, preferences, and how their mind works - to drive engagement and efficacy. We pinpoint data-based digital biomarkers, for enhanced decision-making processes in precise diagnoses, and outcome predictions based on tailored therapies Children engage in a personalized space adventure within a mobile app, aiding characters in overcoming emotional challenges. Mission Amygdala is versatile, serving as standalone treatment or complementing traditional therapy, remote patient monitoring, streamlining care and enhancing patient outcomes. Our early focus group is mild to moderate depression anxiety in children ages 8-12. Calmsie Therapeutics, Inc. (US) Calmsie Sp. z o. o. (PL) Investor contact Marcin Waryszak marcin.waryszak@calmsie.ai